Although mesenteric lymph node CD4+ T cells have been shown to migrate to the liver and promote hepatic inflammation, a decrease of CD4+ T cells in the liver has been reported in NASH models (89), thereby increasing the risk of NASH-to-HCC transition. Here, CD4 is linked to hepatocellular carcinoma.